Author:
Desch Steffen,Eitel Ingo,de Waha Suzanne,Fuernau Georg,Lurz Philipp,Gutberlet Matthias,Schuler Gerhard,Thiele Holger
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference87 articles.
1. Burzykowski T, Molenberghs G, Buyse M, editors: The Evaluation of Surrogate Endpoints. 2005, New York: Springer
2. Clinical Measurement in Drug Evaluation,1995
3. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001, 69: 89-95.
4. Committee for Proprietary Medicinal Products (CPMP). Statistical Prinicples for Clinical Trials (ICH Topic E9). CPMP/ICH/363/96. Book Committee for Proprietary Medicinal Products (CPMP). Statistical Prinicples for Clinical Trials (ICH Topic E9). CPMP/ICH/363/96. 1998, European Medicines Agency City
5. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999, 100: 1992-2002.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献